105
Participants
Start Date
December 13, 2017
Primary Completion Date
July 9, 2018
Study Completion Date
July 9, 2018
Lit control pHDown
Patients within the experimental arm will receive dietary supplement Lit-control®pH Down to help them keep their urinary pH in the adequate levels, being these considered as the preventive ones to avoid stent calcification (pH\<6.2) being the 3 capsule per day indication. On the other hand, the control arm will receive a placebo product with similar organoleptic qualities and the same posology characteristics. Both arms wil use Lit-Control® pH Meter device to keep self- control of the urinary pH; also, both will receive the same hygienic-dietary indications about the care of the stent.
Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela
Hospital Clínico Universitario San Cecilio, Granada
Hospital Universitario La Paz, Madrid
Hospital Álvaro Cunqueiro, Vigo
Hospital Universitari i Politècnic La Fe, Valencia
Hospital Universitario Rio Hortega, Valladolid
Hospital Universitario de Valme, Seville
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat
Fundació Puigvert, Barcelona
Collaborators (1)
Clever Instruments S.L.
INDUSTRY
Devicare S.L.
INDUSTRY